Filing Details
- Accession Number:
- 0001209191-20-038515
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-23 17:01:41
- Reporting Period:
- 2020-06-23
- Accepted Time:
- 2020-06-23 17:01:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1728117 | Gossamer Bio Inc. | GOSS | Pharmaceutical Preparations (2834) | 475461709 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1740847 | Bryan Giraudo | 3013 Science Park Road San Diego CA 92121 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-06-23 | 2,000 | $12.96 | 4,121 | No | 4 | P | Indirect | By family trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By family trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 70,379 | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $12.9606 to $12.962 per share. The price reported above reflects the weighted average sale price for the entire number of shares purchased. Information on the exact number of shares purchased at each sale price can be obtained from the Issuer upon request.
- Includes 46,500 restricted stock units granted in February 2020, which shares will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date.